NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Michael Lattanzi
New York University - New York City / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 846709
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Michael Lattanzi's MOST POPULAR ARTICLES
1-)
Supercapacitor Electrodes with High-energy and power densities prepared from monolithic NiO/Ni NanocompositeQ LuAPS March Meeting Abstracts 2012, B26. 009, 20124192012
2-)
Primary melanoma histologic subtype: impact on survival and response to therapyM Lattanzi, Y Lee, D Simpson, U Moran, F Darvishian, RH Kim, ...JNCI: Journal of the National Cancer Institute 111 (2), 180-188, 2019702019
3-)
Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: a multicenter, single-arm, phase II trialSA Funt, M Lattanzi, K Whiting, H Al-Ahmadie, C Quinlan, MY Teo, ...Journal of Clinical Oncology 40 (12), 1312, 2022522022
4-)
Combined vaccination with NY-ESO-1 protein, poly-ICLC, and montanide improves humoral and cellular immune responses in patients with high-risk melanomaA Pavlick, AB Blazquez, M Meseck, M Lattanzi, PA Ott, TU Marron, ...Cancer immunology research 8 (1), 70-80, 2020562020
5-)
The emerging role of antibody-drug conjugates in urothelial carcinomaM Lattanzi, JE RosenbergExpert review of anticancer therapy 20 (7), 551-561, 2020312020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept